Publication at First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine |
1998
Abstract
Neuroblastoma is the second most common solid tumor in children. The prognosis is poor for approximately 70% of patients who have widespread disease at the time of diagnosis.
The use of new strategies for classification and therapy has raised expectations for cure in advanced neuroblastoma. We summarise results and experiences reached during the last decade.